Liu, W.; Wang, L.; Zhang, J.; Cheng, K.; Zheng, W.; Ma, Z.
CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway. Int. J. Mol. Sci. 2023, 24, 10652.
https://doi.org/10.3390/ijms241310652
AMA Style
Liu W, Wang L, Zhang J, Cheng K, Zheng W, Ma Z.
CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway. International Journal of Molecular Sciences. 2023; 24(13):10652.
https://doi.org/10.3390/ijms241310652
Chicago/Turabian Style
Liu, Wei, Lei Wang, Jiajia Zhang, Kun Cheng, Wenming Zheng, and Zhenling Ma.
2023. "CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway" International Journal of Molecular Sciences 24, no. 13: 10652.
https://doi.org/10.3390/ijms241310652
APA Style
Liu, W., Wang, L., Zhang, J., Cheng, K., Zheng, W., & Ma, Z.
(2023). CC Chemokine 2 Promotes Ovarian Cancer Progression through the MEK/ERK/MAP3K19 Signaling Pathway. International Journal of Molecular Sciences, 24(13), 10652.
https://doi.org/10.3390/ijms241310652